Optovue, founded in December 2003, is a leading ophthalmic device company based in Fremont, California. Known for its commitment to pioneering the future of ocular diagnostics, the company works in concert with eye care professionals and clinical researchers to innovate and enhance eye care with its next-generation imaging technologies.
Central to Optovue's offering is its advanced Fourier-Domain Optical Coherence Tomography (FD-OCT) technology, which delivers ultra-high speed, high-resolution imaging for superior retinal diagnostics. This technology significantly aids in diagnosing and treating conditions such as macular degeneration, diabetic retinopathy, and glaucoma, thus improving patient outcomes.
The company aligns itself within the Health Care and Medical Devices industries. Optovue's most recent financial backing occurred on 11 November 2015, when they secured a $30.00M investment in a Private Equity Round from Delta Power Solutions. This investment underscores confidence in Optovue's cutting-edge contributions to ocular health.
